Valeant Pharma (VRX), Subsidiary Commence Cash Tender Offers For Up to $1B Outstanding Principal Amount
Tweet Send to a Friend
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) and Valeant Pharmaceuticals International ("VPI," and together with Valeant, the "Offerors"), a wholly-owned subsidiary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE